🔎 Trials Near Me

Nyumbani › Leukemia › Maryland › Baltimore

Majaribio ya kliniki ya Leukemia katika Baltimore, MD

Masomo 5 ya Leukemia yanatafuta washiriki katika vituo vya Baltimore na maeneo yake (ndani ya takriban maili 30). Fungua somo kuona nani anaweza kujiunga na jinsi ya kuwasiliana na timu ya utafiti.

Maandishi rasmi ya utafiti (Kiingereza)

Unavutia washiriki kwa utafiti hapa? Weka juu ya ukurasa huu — $99 kwa siku 30 →

Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia

InaajiriHatua 3
  • Quetzal Site 23, Baltimore
Umri 18 hadi 71 · Jinsia zote · Imesasishwa 23 Sep 2026 · NCT07504458

Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission

InaajiriHatua 2
  • John Hopkins School of Medicine, Baltimore
Umri 18 na zaidi · Jinsia zote · Imesasishwa 16 Sep 2026 · NCT06824168

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

InaajiriUtafiti wa uchunguzi
  • Sinai Hospital of Baltimore, Baltimore
  • Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Umri wote · Jinsia zote · Imesasishwa 18 Mei 2026 · NCT01790152

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

InaajiriHatua 1
  • Johns Hopkins School of Medicine, Baltimore
Umri 18 na zaidi · Jinsia zote · Imesasishwa 13 Mac 2026 · NCT05735184

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

InaajiriUtafiti wa uchunguzi
  • Massive Bio SYNERGY-AI site, Baltimore
  • Massive Bio SYNERGY-AI site, Towson · Mi 8 mbali
Umri wote · Jinsia zote · Imesasishwa 28 Okt 2025 · NCT03452774

Majaribio ya Leukemia katika miji mingine

Masomo mengine katika Baltimore

Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.